$2.600
-0.151 (-5.80%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BLRX por análisis de gráficos similares
Alphio's BLRX stock price prediction model matches the current BioLine RX Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.62 (+0.61%). The 1-week path is $2.60 (+0.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de BioLine RX Ltd?
Currently, BioLine RX Ltd (BLRX) is not a strong buy due to its recent performance and financial instability. The stock price is at $2.60, with a 1-year change of -30.67%, indicating a significant decline over the past year. Additionally, the RSI is at 36.368, suggesting that the stock is nearing oversold territory but is not yet a clear buy signal. The forward P/E ratio is extremely high at 93.46, which raises concerns about valuation. The main risk is the company's negative net income, which was -$2.24 million in the last quarter, indicating ongoing financial struggles. Overall, while there are some positive indicators, such as a recent earnings beat and revenue growth, the financial instability and high valuation suggest that investors should hold off on buying until there are clearer signs of recovery.
BLRX cerró en $2.60 el Friday, tras bajar -5.80%
BioLine RX Ltd (BLRX) last closed at $2.6, losing -5.80%. These facts feed the 1-day and 1-week BLRX price prediction above.
Consenso de analistas
BioLine RX Ltd (BLRX): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de BioLine RX Ltd (BLRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BLRX, ordenadas por similitud.
Análisis de estacionalidad de BLRX
Historically the probability of a positive August return for BLRX is 7.94%. January offers the highest probability of a positive month at 36.07%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BLRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $3.45 | $3.96 | $4.54 | +52.38% |
| Sep 2026 | $4.59 | $4.98 | $5.00 | +91.53% |
| Oct 2026 | $4.57 | $4.89 | $5.21 | +87.99% |
| Nov 2026 | $4.47 | $4.73 | $5.11 | +81.96% |
| Dec 2026 | $4.26 | $4.62 | $4.97 | +77.64% |
En 2026, se proyecta que BioLine RX Ltd (BLRX) oscile entre $3.45 y $5.21.
Previsión mensual de BioLine RX Ltd para 2026
En Aug de 2026, se proyecta que BioLine RX Ltd promedie $3.96, con un mínimo de $3.45 y un máximo de $4.54.
En Sep de 2026, se proyecta que BioLine RX Ltd promedie $4.98, con un mínimo de $4.59 y un máximo de $5.00.
En Oct de 2026, se proyecta que BioLine RX Ltd promedie $4.89, con un mínimo de $4.57 y un máximo de $5.21.
En Nov de 2026, se proyecta que BioLine RX Ltd promedie $4.73, con un mínimo de $4.47 y un máximo de $5.11.
En Dec de 2026, se proyecta que BioLine RX Ltd promedie $4.62, con un mínimo de $4.26 y un máximo de $4.97.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.